Tumor markers in endometriosis
- PMID: 10458545
- DOI: 10.1016/s0020-7292(99)00046-6
Tumor markers in endometriosis
Abstract
Objectives: The objective of the present study was to determine the concentrations of CA 125, CA 15-3, CA 19-9, carcioembryogenic antigen (CEA), alpha-fetoprotein (AFP) and beta-2 microglobulin (B2MG) in patients with pelvic endometriosis.
Method: Fifty women were divided into two groups: group A (control) had no endometriosis or other diseases, and group B consisted of 35 women with pelvic endometriosis. All women were submitted to serum determination of CA 125, CA 15-3, CA 19-9, CEA, AFP and B2MG. Samples were collected during the menstrual cycle and 1 week later.
Results: Mean CA 125 concentrations were altered in patients with endometriosis, but all 50 patients studied presented normal CEA, AFP and B2MG concentrations. Small variations detected in CA 19-9 and CA 15-3 had no statistical significance.
Conclusion: CA 125 is the only important marker in the diagnosis of stages III/IV of endometriosis, especially when blood samples for its determination are obtained during the first 3 days of the menstrual cycle.
Similar articles
-
[The use of biochemical markers in diagnosis of endometriosis].Akush Ginekol (Sofiia). 2008;47(4):19-22. Akush Ginekol (Sofiia). 2008. PMID: 19230253 Bulgarian.
-
The use of biochemical markers in the diagnosis of pelvic endometriosis.Hum Reprod. 1997 Nov;12(11):2523-7. doi: 10.1093/humrep/12.11.2523. Hum Reprod. 1997. PMID: 9436699
-
Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.J Clin Lab Anal. 2007;21(3):193-6. doi: 10.1002/jcla.20168. J Clin Lab Anal. 2007. PMID: 17506483 Free PMC article. Clinical Trial.
-
Laboratory testing for endometriosis.Clin Chim Acta. 2004 Feb;340(1-2):41-56. doi: 10.1016/j.cccn.2003.10.021. Clin Chim Acta. 2004. PMID: 14734195 Review.
-
[Endometriosis in adolescence - characteristic features].Akush Ginekol (Sofiia). 2000;40(4):24-6. Akush Ginekol (Sofiia). 2000. PMID: 11288627 Review. Bulgarian.
Cited by
-
Peripheral biomarkers of endometriosis: a systematic review.Hum Reprod Update. 2010 Nov-Dec;16(6):651-74. doi: 10.1093/humupd/dmq009. Epub 2010 May 12. Hum Reprod Update. 2010. PMID: 20462942 Free PMC article.
-
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?Front Oncol. 2022 Sep 21;12:946319. doi: 10.3389/fonc.2022.946319. eCollection 2022. Front Oncol. 2022. PMID: 36212445 Free PMC article.
-
MicroRNAs Dysregulation as Potential Biomarkers for Early Diagnosis of Endometriosis.Biomedicines. 2022 Oct 13;10(10):2558. doi: 10.3390/biomedicines10102558. Biomedicines. 2022. PMID: 36289820 Free PMC article. Review.
-
Blood biomarkers for the non-invasive diagnosis of endometriosis.Cochrane Database Syst Rev. 2016 May 1;2016(5):CD012179. doi: 10.1002/14651858.CD012179. Cochrane Database Syst Rev. 2016. PMID: 27132058 Free PMC article.
-
Clinical Management of Endometriosis in Menopause: A Narrative Review.Medicina (Kaunas). 2024 Aug 18;60(8):1341. doi: 10.3390/medicina60081341. Medicina (Kaunas). 2024. PMID: 39202622 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials